Sorin launches Ovatio ICDs (implantable cardioverter defibrillators) in Japan:
This article was originally published in Clinica
Executive Summary
Sorin Group has launched its Ovatio DR implantable cardioverter defibrillators (ICDs) in Japan. The Milan, Italy company claims that the Ovatio product line comprises the world's smallest such devices, and hence that their thinness suits for Japanese body size. The single and dual chamber models, Ovatio VR 6250 and DR 6550 ICD, have received regulatory and reimbursement approval from the Japanese health ministry (MHLW). Both models are immediately available. The dual chamber Ovatio DR includes a feature designed to reduce unnecessary stimulation in the right ventricle, thus decreasing the risk of heart failure and atrial fibrillation, as well as a component intended to protect patients from inappropriate shocks.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.